The size of the North America Cell Harvesting Systems Market was around USD 1.35 billion in 2022. It is expected to grow at a CAGR of 8.20% to reach USD 2.01 billion by 2027. Increased investments in stem cell research in the United States and the rising proportion of the aged population fuels North America's market growth.
In the US, chronic diseases are the leading cause of death and disability. According to the Centers for Diseases Control and Prevention and an estimated 133 million Americans, i.e., 45% of the population are diagnosed with at least one chronic disease and lifestyle-related chronic diseases. Moreover, growing cardiovascular diseases, key players in cell harvesters play a crucial role in treating large and different types of diseases like cancer, immune deficiency diseases, and blood-related diseases that escalate this region's market growth. Stem cell products approved by the FDA in the U.S., containing blood-forming stem cells derived from cord blood, the surge in the number of infectious diseases, and therapies in the region have anticipated the market growth.
Hazardousness and drawbacks of the treatment, difficulties soaring during the cell harvesting are impeding the market growth. Also, the expensive nature of the cell harvesting and shortage of adequate reimbursement policies to hamper the market growth during the period.
This market research report on the North America Cell Harvesting Systems Market has been segmented & sub-segmented into the following categories:
By End User:
The cell harvesting systems market in North America is anticipated to govern the cell harvesting market due to the growing portion of the elder people population, increasing investments in regenerative medicine and cell-based research, and surge in the biotechnology biopharmaceutical market.
The U.S is leading the cell harvesting systems market. Rise in the number of bone marrow transplantation cases due to regular increase of blood cancer and anemia where nearly 60,000 patients are treated with bone marrow transplantations every year, growing healthcare infrastructure, and steady growth of leukemia lymphoma are leveling up the demand of the market. Around 1,735,350 cancer cases were diagnosed in the U.S in 2018, according to the Leukemia and Lymphoma Society 2018.
Canada is closely following the United States. It is expected to have considerable growth in the market due to urbanization, escalating obesity levels, changing diet habits, and motionless lifestyles that augment market growth during this region. The US cell harvesting systems market is based on a surge in health research expenditure and government initiatives.
The leading players in the North American cell harvesting systems market profiled in this report are Avita Medical; Tomtec; Terumo Corporation; Perkin Elmer, Inc; Argos Technologies, Inc; Bertin Technologies; Arthrex, Inc; Brand GmBh + CO KG; Thomas Scientific; and Tereflex, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]